Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7618)
All Articles published online
|
Publishing Process of This Article
|
Jun 9, 2025 (publication date) through Sep 27, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Pediatrics
ISSN
2219-2808
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Semwal P, Saini MK, Sarma MS. Understanding antituberculosis drug-induced hepatotoxicity: Risk factors and effective management strategies in the pediatric population. World J Clin Pediatr 2025; 14(2): 101875 [PMID: 40491731 DOI: 10.5409/wjcp.v14.i2.101875] |
|---|---|
| URL: | https://www.wjgnet.com/2219-2808/full/v14/i2/101875.htm |
| Number | Citing Articles |
| 1 |
Jason E. Cummings, Lisa K. Woolhiser, Vincent Guglielmi, Machenzie Wernsman, Ashley Romano, Samantha Pauly, John T. Belisle, Nicholas D. Walter, Gregory T. Robertson, Richard A. Slayden. Evaluating the efficacy of HRZE-based regimens in a high-burden murine model: a back-translational assessment of rifamycins and moxifloxacin substitutions in tuberculosis treatment. Frontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1667592
|
| 2 |
Eko Indra Noviansyah, Irawaty Djaharuddin, Harry Akza Putrawan, Jamaluddin Madolangan, Bulkis Natsir, Edward Pandu. The Effect of Hepatoprotectors on the Risk of Drug-induced Hepatitis in Pulmonary Tuberculosis Patients. The International Journal of Mycobacteriology 2025; 14(3): 219 doi: 10.4103/ijmy.ijmy_67_25
|